149 results
Page 5 of 8
D
p6qlms5n dc3
14 Apr 20
$460K in options / securities to be acquired, sold $460K, 1 investor
2:28pm
8-K
EX-99.1
qjomtt8ukf nyj2pd9l4
14 Apr 20
Akers Biosciences and Premas Biotech Announce Successful Expression of Coronavirus Antigens
9:20am
424B5
hfkcl4l
8 Apr 20
Prospectus supplement for primary offering
9:16am
8-K
EX-99.1
1wy2 850m
8 Apr 20
Entry into a Material Definitive Agreement
6:21am
D
egasu5xi6c
7 Apr 20
$2.72M in equity / securities to be acquired, sold $1.23M, 4 investors
5:11pm
8-K
EX-10.2
fu5h8ft09kbo1q4k725b
24 Mar 20
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
9:21am
8-K
EX-10.1
6de63v83
24 Mar 20
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
9:21am
8-K
EX-10.4
z0krzpuy
24 Mar 20
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
9:21am
8-K
EX-10.1
bvyeybo3p5ix9r9najgc
31 Jan 20
Departure of Directors or Certain Officers
5:04pm
8-K
1t67s
17 Jan 20
Regulation FD Disclosure
5:00pm
424B4
2g5m7h2uad4ftunh0
9 Dec 19
Prospectus supplement with pricing info
6:08am